BTG3 and juvenile idiopathic arthritis: In perhaps the largest study to date addressing this question, there were no significant differences found relating to ANA positivity in Danish children with JIA and the number of active joints at follow-up, remission rate on medication for more than 6 months, or remission rate off medication for more than 12 months.